Decoding Novavax's Options Activity: What's the Big Picture?
Decoding Novavax's Options Activity: What's the Big Picture?
Whales with a lot of money to spend have taken a noticeably bullish stance on Novavax.
有大量資金可用的鯨魚已經明顯看好諾瓦瓦克斯醫藥。
Looking at options history for Novavax (NASDAQ:NVAX) we detected 10 trades.
我們檢測到了10筆諾瓦瓦克斯醫藥期權交易歷史記錄。
If we consider the specifics of each trade, it is accurate to state that 80% of the investors opened trades with bullish expectations and 20% with bearish.
如果我們考慮每個交易的具體情況，可以準確地說80%的投資者以看好的預期開倉，20%以看淡的預期開倉。
From the overall spotted trades, 3 are puts, for a total amount of $238,432 and 7, calls, for a total amount of $255,012.
從整個檢測到的交易來看，有3份看跌期權，總金額爲238,432美元，有7份看漲期權，總金額爲255,012美元。
Predicted Price Range
預測價格區間
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $7.5 to $17.5 for Novavax over the last 3 months.
考慮到這些合同的成交量和持倉量，過去3個月來，鯨魚們已經將目標價位定在了7.5美元至17.5美元之間。
Insights into Volume & Open Interest
成交量和持倉量分析
In today's trading context, the average open interest for options of Novavax stands at 1732.0, with a total volume reaching 953.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Novavax, situated within the strike price corridor from $7.5 to $17.5, throughout the last 30 days.
在今天的交易環境中，諾瓦瓦克斯醫藥期權的平均持倉量爲1732.0，總成交量爲953.00。下圖描述了過去30天內位於7.5美元至17.5美元行權價格走廊內的高價值交易的看漲和看跌期權成交量和持倉量的進展情況。
Novavax Option Volume And Open Interest Over Last 30 Days
諾瓦瓦克斯醫藥期權成交量和持倉量過去30天的情況
Largest Options Trades Observed:
觀察到的最大期權交易：
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NVAX | PUT | SWEEP | BULLISH | 01/17/25 | $0.79 | $0.66 | $0.66 | $7.50 | $108.3K | 3.5K | 4 |
| NVAX | PUT | SWEEP | BEARISH | 07/12/24 | $2.27 | $1.98 | $2.02 | $15.00 | $72.9K | 27 | 0 |
| NVAX | PUT | SWEEP | BULLISH | 01/17/25 | $6.2 | $6.15 | $6.15 | $17.50 | $57.2K | 3.0K | 1 |
| NVAX | CALL | TRADE | BULLISH | 01/16/26 | $7.9 | $7.3 | $7.86 | $7.50 | $39.3K | 1.7K | 150 |
| NVAX | CALL | TRADE | BULLISH | 01/16/26 | $7.9 | $7.3 | $7.75 | $7.50 | $38.7K | 1.7K | 100 |
| 標的 | 看跌/看漲 | 交易類型 | 情緒 | 到期日 | 賣盤 | 買盤 | 價格 | 執行價格 | 總交易價格 | 未平倉合約數量 | 成交量 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NVAX | 看跌 | SWEEP | 看好 | 01/17/25 | $0.79 | $0.66 | $0.66 | $7.50 | $108.3K | 3.5K | 4 |
| NVAX | 看跌 | SWEEP | 看淡 | 07/12/24 | 2.27美元 | $1.98 | $2.02 | 15.00美元 | $72.9K | 27 | 0 |
| NVAX | 看跌 | SWEEP | 看好 | 01/17/25 | $6.2 | $ 6.15 | $ 6.15 | $17.50 | $57.2K | 3.0K | 1 |
| NVAX | 看漲 | 交易 | 看好 | 01/16/26 | $7.9 | $7.3 | $7.86 | $7.50 | $39.3K | 1.7K | 150 |
| NVAX | 看漲 | 交易 | 看好 | 01/16/26 | $7.9 | $7.3 | $7.75 | $7.50 | $38.7K | 1.7K | 100 |
About Novavax
關於諾瓦瓦克斯
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The Company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from Europe.
諾瓦瓦克斯公司是一家開發疫苗的生物技術公司。該公司在開發的臨床階段致力於推出預防廣泛疾病的新產品。諾瓦瓦克斯與其全資擁有的瑞典子公司合作，生產能夠應對已知和新出現的疾病威脅的疫苗候選品。該公司認爲其疫苗技術具有廣泛應用於多種人類傳染性疾病的潛力。該公司將其業務管理爲一個經營部門，即疫苗的研發和商業化。該公司從歐洲獲取最大收入。
In light of the recent options history for Novavax, it's now appropriate to focus on the company itself. We aim to explore its current performance.
鑑於諾瓦瓦克斯的近期期權交易歷史，現在適合關注該公司本身。我們旨在探討其當前表現。
Novavax's Current Market Status
諾瓦瓦克斯醫藥的當前市場狀態
- Trading volume stands at 5,226,531, with NVAX's price down by -7.32%, positioned at $12.97.
- RSI indicators show the stock to be is currently neutral between overbought and oversold.
- Earnings announcement expected in 41 days.
- 交易量爲5,226,531股，NVAX的價格下跌了-7.32%，位於12.97美元位置。
- RSI指標顯示該股票目前處於超買和超賣之間的中立狀態。
- 盈利公告預計還有41天。
Professional Analyst Ratings for Novavax
諾瓦瓦克斯醫藥的專業分析師評級
A total of 1 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $18.0.
在過去30天中，共有1位專業分析師對這隻股票發表了看法，設定了平均目標價爲18.0美元。
- Consistent in their evaluation, an analyst from B of A Securities keeps a Neutral rating on Novavax with a target price of $18.
- 在他們的評估中，B of A Securities的一位分析師給出了中立評級，目標價爲18美元。
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Novavax options trades with real-time alerts from Benzinga Pro.
期權交易存在更高的風險和潛在回報。精明的交易者通過不斷學習、調整策略、監測多個因子並密切關注市場走勢來管理這些風險。通過Benzinga Pro即時警報，了解最新的諾瓦瓦克斯醫藥期權交易情況。
譯文內容由第三人軟體翻譯。